tablet-yellow

Ipratropium (Atrovent, Atrovent HFA)

Anesthesia Implications

Clinically reviewed by anesthesia providers · Updated

Classification:
Quaternary anticholinergic, muscarinic receptor antagonist, inhaled bronchodilator
Therapeutic Effects:
Bronchodilation, reduction of airway mucus secretion
Primary Considerations:

Bronchospasm management - Useful adjunct to short-acting beta-2 agonists for intraoperative bronchospasm and for COPD / asthma exacerbations; the combination produces greater bronchodilation than...

Continue reading

Read the full drug post with a free account

Free. It opens every drug, surgery and condition in the library.

Already have an account?